beta

AKER

Akers Biosciences, Inc.

Aker

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.

Market Cap: 3.36 Million

Primary Exchange: NASDAQ

Website: http://www.akersbio.com

Shares Outstanding: 12.5 Million

Float: 12.5 Million

Dividend: (%)

Beta: 1.74317429204776

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Longest drawdown: 1991 trading days

From: 2013-10-21 To: 2019-11-19

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud